Medtech startup with a neurotechnology wearable (Nettle) offering a drug-free solution for PMS and menstrual pain.
| Date | Round | Amount |
|---|---|---|
| Feb 2024 | Pre Seed Samphire Neuroscience secured $2.3M in pre-seed funding from SOSV and others to launch its Nettle neurostimulation wearable for PMS and period pain. | $2.3M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.